Please ensure Javascript is enabled for purposes of website accessibility
Veracyte Stock Quote

Veracyte (NASDAQ: VCYT)

$29.14
(1.1%)
$0.31
Price as of December 2, 2022, 4:00 p.m. ET

You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Veracyte Returns vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
VCYT -25.70% +335.58% +34.18% +120%
S&P -11.04% +54.10% +9.02% +131%

Veracyte Company Info

Veracyte Inc is engaged in the discovery, development, and commercialization of molecular cytology solutions that enable physicians to make more informed treatment decisions at an early stage in patient treatment.

News & Analysis

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
376%
 
S&P 500 Returns
119%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 12/05/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.